Journal
EXPERT OPINION ON DRUG DISCOVERY
Volume 2, Issue 6, Pages 799-808Publisher
TAYLOR & FRANCIS LTD
DOI: 10.1517/17460441.2.6.799
Keywords
antibiotics; disordered proteins; drug targets; fungicides; genomics; multi-target drugs; networks; network damage; pesticides; phosphorylation; protein kinases; proteomics; signaling networks
Categories
Funding
- EU [FP6-518230, FP6-016003]
- Hungarian Office of Research and Development [NFKP-1A/056/2004]
Ask authors/readers for more resources
Despite improved rational drug design and a remarkable progress in genomic, proteomic and high-throughput screening methods, the number of novel, single-target drugs has fallen far behind expectations during the past decade. Multi-target drugs multiply the number of pharmacologically relevant target molecules by introducing a set of indirect, network-dependent effects. Parallel with this, the low-affinity binding of multi-target drugs eases the constraints of druggability and significantly increases the size of the druggable proteome. These effects tremendously expand the number of potential drug targets and introduce novel classes of multi-target drugs with smaller side effects and toxicity. Here, the authors review the recent progress in this field, compare possible network attack strategies and propose several methods to find target-sets for multi-target drugs.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available